Delivery Order SPE2DB20D9136-SPE2DB25FJ59Q
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,322.50 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This firm fixed-price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 22, 2025, and is not designated under any specific set-aside program. The delivery will be performed at the vendor's Park Ridge, Illinois location. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a task order under the company's larger single-award Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a $2,083.12 firm fixed-price delivery order by the Defense Logistics Agency for Mirena 52 mg contraceptive systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a specific purchase order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion and valid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,645.39 by the Defense Logistics Agency (DLA) for Mirena 52 mg systems. The contract, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order without a set-aside designation. This award represents a direct delivery under DMS Pharmaceutical Group's existing Indefinite...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 52 milligram Mirena systems valued at $4,686.93. This firm fixed-price delivery order, awarded July 30, 2025, with an ultimate completion date of August 20, 2025, represents performance at the contractor's Park Ridge facility. The award carries no set-aside designation and falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $5,207.70 with an ultimate completion date of August 21, 2025, was issued without a set-aside designation. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 21, 2025, for Mirena 52 mg systems with a ceiling value of $6,249.24. This firm fixed-price delivery order, which is expected to be completed by August 11, 2025, was awarded without a set-aside designation. The award represents a continuation of the company's role as a critical supplier within...
- The Defense Logistics Agency awarded a $6,249.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Mirena 52 mg systems. The award was issued on July 28, 2025, with an ultimate completion date of August 18, 2025. No set-aside designation was used for this procurement. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency awarded a $2,603.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg contraceptive systems on July 29, 2025, with an ultimate completion date of August 19, 2025. This delivery order was issued without a set-aside designation and is being performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, is the prime contractor on this award. This delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,124.62 on July 24, 2025, for the supply of Mirena 20mcg/24hr contraceptive implants. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The contract specifies Park Ridge, Illinois...
- SPE2DB20D9136Indefinite Delivery Contract
- SPE2DB20D9136-SPE2DB25FJ59QDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order for 52 mg Mirena systems valued at $2,083.12 by the Defense Logistics Agency (DLA). Issued on August 1, 2025, with an ultimate completion date of August 22, 2025, this firm fixed-price delivery order is being performed at the contractor's facility in Park Ridge, Illinois. The award utilized no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis leveraging its established market position within federal pharmaceutical procurement. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA, valued at $499,999,999 and valid through November 2026. The parent IDC, executed under the SPE2DB program, authorizes the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting Department of Defense healthcare facilities worldwide. Mirena systems, a contraceptive medical device, fall within the extensive product portfolio covered under the indefinite delivery contract, which encompasses branded and generic prescription medications, biologics, over-the-counter items, and specialized medical consumables. This positioning establishes DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/1/25 |